Methods: Never-lesional skin from patients with psoriasis (NLP) was collected from those with mild disease. T-cell profiles were assessed by using confocal imaging and flow cytometry. Tissue responses to T-cell stimulation were measured by using multiplex and NanoString technology. Results: T-cell activation ex vivo triggered psoriasiform and type I interferon tissue responses in NLP psoriasis. Accordingly, keratinocytes from NLP responded to IFN-g stimulation with myxovirus 1 (MX1) expression and IFN-a release. Additionally, CCR6-expressing resident T cells poised to produce IFN-g and IL-17 were enriched in epidermis from NLP, whereas dermal tissue responses and T-cell compositions were similar to those in healthy skin. Finally, keratinocytes from NLP exposed to IL-17 and skin explants exposed to common fungal antigens responded with upregulation of the CCR6 ligand CCL20. Psoriasis is triggered by environmental factors in genetically predisposed subjects. 1 Chronic psoriatic lesions are sustained by continuous interactions between infiltrating immune cells and activated keratinocytes. 2 The cytokines TNF, IL-17, and IL-23 are pivotal signals to maintain psoriasis pathology, as proved by the efficient disease control provided by systemic inhibition of these cytokines. Conversely, treatment with IFN-a or IFN-g can trigger psoriasis flares, [3] [4] [5] indicating that these cytokines might steer the initial phase of lesion formation or recurrence. One proposed key signal to trigger keratinocyte activation and psoriasiform inflammation in new lesions is IFN-a, which has been shown to be secreted by accumulated plasmacytoid dendritic cells (pDCs) in early lesions. 6 Psoriasis plaques typically develop and recur on a few sites on the body, and new plaques can evolve in new skin sites during life. In patients with severe psoriasis, skin that lacks macroscopic signs of disease displays a ''prepsoriatic'' transcriptional profile and harbors increased numbers of T cells. 7, 8 Keratinocytes from such skin exhibit modified expression of genes involved in differentiation 9 and differently cytokine-responses compared with cells from healthy skin. 10, 11 Resident T cells are implicated in the de novo evolution of psoriasis plaques in nonlesional skin transplanted to immunodeficient mice, [12] [13] [14] and it has been postulated that regulatory CD4 T cells inhibit the evolution of new lesions in never-lesional skin. 15 Human skin harbors several functionally distinct subsets of resident T cells, 16, 17 and we and other have shown that IL-17-and IL-22-producing resident T cells are enriched in resolved lesions. [18] [19] [20] Despite convincing evidence that nonlesional skin in patients with severe psoriasis differs from healthy skin, the composition of resident T cells or potential mechanisms by which such cells could initiate psoriasiform pathology in never-lesional skin from patients with psoriasis (NLP) is less known.
Here we show that activation of a skewed pool of resident T cells initiated psoriasiform tissue responses in skin explants of NLP from those with mild disease. CCR6
1 CD4 T cells and CD103
1

CD49a
2 CD8 T cells poised to the production of psoriasis-associated cytokines IL-17, IL-22, or both were enriched in the pool of resident T cells. Additionally, accumulation of IFN-g-producing T cells, including cells coproducing IFN-g and IL-17, was evident. Intriguingly, IFN-g elicited IFN-a release from keratinocytes, thereby introducing an additional source of IFN-a during de novo formation of psoriatic lesions. Finally, fungal antigens induced upregulation of the CCR6 ligand CCL20 in keratinocytes from NLP, suggesting a mechanism driving accumulation of intraepidermal CCR6 1 T cells.
METHODS
Human skin samples
Skin from healthy subjects was obtained from the Department of Reconstructive Plastic Surgery, Karolinska University Hospital, Stockholm, Sweden. Patients with psoriasis were recruited through the Psoriasis Association Clinic (see Table E1 in this article's Online Repository at www.jacionline.org). Biopsy specimens were processed within 4 hours or immediately cryopreserved at 2808C. NLP was collected at least 10 cm from lesions in sites never affected by psoriasis according to the patient history (Fig 1, A) . Samples were collected according to the Declaration of Helsinki Principles (regional ethical committee of Stockholm, reference no, 2012/50-31/2). Signed consent forms were collected for all patients.
Confocal microscopy
Cryopreserved biopsy specimens were prepared, as previously described. 16, 18 Antibodies used for confocal microscopy are listed in Table E2 in this article's Online Repository at www.jacionline.org. Images were acquired with a laser scanning confocal microscopy (LSM800) using Zen software (Zeiss, Oberkochen, Germany) and analyzed with Fiji software (ImageJ; National Institute of Health, Bethesda, Md).
48-well plates. At 100% confluence, cultures were exposed to recombinant human (rh) IL-17A (5 ng/mL), rhIL-22 (5 ng/mL), rhTNF (5 ng/mL), rhIFN-a (5 U/mL), or rhIFN-g (5 ng/mL) (all from R&D Systems, Minneapolis, Minn) for 16 hours.
Ex vivo exposure of skin biopsy specimens
Full-thickness skin biopsy specimens were incubated with aCD3 antibody (1 mg/mL; clone OKT-3; CD3ε), IgG 2a control (1 mg/mL; Ultra LEAF; BioLegend, San Diego, Calif), IL-17A (100 ng/mL; 7955-IL-025; R&D . Fig 1, C, Illustration of the PCA vectors clustering plaque psoriasis (PP) away from NLP, skin from healthy control subjects (HC), and skin from patients with resolved psoriasis (RP). D, Baseline gene expression in epidermis analyzed by using quantitative PCR. HC, n 5 4 to 7; NLP, n 5 8; patients with RP, n 5 9 to 10; patients with PP, n 5 6 to 11. RQ, Relative quantification. E-H, Skin explants were incubated with OKT-3 or IgG 2a (1 mg/mL) and analyzed by using NanoString technology after separation of epidermis and dermis (n 5 5 per group). Fig 1, F , Gene ontology (GO) pathways visualized with Cytoscape (ClueGO) analyzing differentially expressed genes between OKT-3-and IgG 2a -exposed epidermis from NLP. Fig 1, G , Venn diagram depicting genes upregulated at baseline in epidermis from patients with PP versus HC epidermis (orange) and differentially expressed genes between OKT-3-and IgG 2a -exposed samples in NLP (blue) and HCs (red) epidermis. Fig 1, H , GO pathways using differentially expressed genes in epidermis from NLP epidermis on OKT-3 stimulation. *P < .05. NS, Not significant. Systems), IFN-g (100 ng/mL; 285-IFN-100; R&D Systems), heat-killed Candida albicans (5 3 10 6 /mL; InvivoGen, San Diego, Calif), and mannan of Saccharomyces cerevisiae (100 mg/mL; Sigma-Aldrich) for 16 to 48 hours at 378C, as previously described. 20 Supernatants were immediately cryopreserved at 2808C. There were 9 healthy control subjects and 10 patients with psoriasis for the fungal experiments. There were 5 in each group for skin exposure to IL-17 and IFN-g.
RNA extraction and quantitative PCR
The epidermis and dermis were separated; RNA was extracted from either stimulated skin biopsy specimens, or sorted cells, or cultured keratinocytes; and quantitative PCR was performed, as previously described. 20 Gene expression was normalized to the housekeeping gene b 2 -microglobulin (B2M), and all quantitative PCR results show relative quantification as follows:
Primer/probe-conjugated TaqMan Gene Expression Assays were ordered from Applied Biosystems (Foster City, Calif; see Table E2 ).
NanoString analysis
NanoString counting was performed on mRNA, according to the manufacturer's protocol (Custom CodeSet; NanoString Technologies, Seattle, Wash). Counts were generated in nSolver software (NanoString Technologies). Five samples per group of patients were analyzed. The complete panel of transcripts analyzed and housekeeping genes are presented in Table E3 in this article's Online Repository at www.jacionline.org.
Protein analysis of supernatants
Supernatants were analyzed with ProcartaPlex (eBioscience, San Diego, Calif), according to the manufacturer's protocol, and read with the Bio-Plex 200 System (Bio-Rad Laboratories, Hercules, Calif) or CCL20 ELISA (Quantikine ELISA Kit Human CCL20/MIP-3a; R&D Systems) read with the Spectramax Plus 284 (Molecular Devices, Sunnyval, Calif). The cutoff for detection was set at 10 pg/mL (median per triplicate).
Statistical analysis
Statistical analyses and graphic illustrations were performed with Prism software (version 6; GraphPad Software, La Jolla, Calif) or JMP 12 software (SAS Institute, Cary, NC). Heat maps were generated by using the Multi Experiment Viewer (www.tm4.org/mev.html). The Mann-Whitney U test or Wilcoxon matched-pairs signed-rank test was used for testing independent or paired data. Linear regression was performed with Prism software. Correlations were determined by using the Pearson test. FlowJo software (version 9.9; TreeStar, Ashland, Ore) was used to analyze flow cytometric data. Barnes-Hut t-distributed stochastic neighbor embedding analysis of 13-parametr data was performed on live CD3
1 T cells, as previously described. 22 For data analyses and graphic visualizations, the R packages Rtsne, plyr, Hmisc, gplots, MASS, ggplot2, grid, and RColorBrewer were used. 23 
RESULTS
NLP responds to T-cell activation with psoriasis-associated genes
Transcriptional alterations in nonlesional skin from patients with severe psoriasis 7 might reflect a combination of local and systemic immune alterations present in patients with severe psoriasis. To avoid systemic influence on local immune homeostasis, we focused on NLP in patients with mild disease and collected skin samples at least 10 cm from the borders of active lesions (Fig 1, A) . Baseline expression of 112 genes implicated in psoriasis pathology and skin inflammation was quantified by using NanoString and compared with recently published data on patients with active plaque psoriasis, patients with resolved psoriasis, and healthy control subjetcs. 20 Principal component analysis separated lesional epidermis from NLP, patients with resolved psoriasis, and healthy control subjects (Fig 1, B) , highlighting similarities in baseline expression between tissue from NLP and healthy control subjects.
Interestingly, principal component analysis did not separate out any of the investigated groups in dermis (see Fig E1, A, in this article's Online Repository at www.jacionline.org). Several proposed psoriasis biomarkers, such as the antimicrobial peptide DEFB4A/B and the chemokines CCL20 and CXCL10, [24] [25] [26] were among the transcripts that separated psoriatic lesions from NLP and healthy control subjects (Fig 1, C) . Expression of both CXCL10 and CCL20, but not DEFB4A/B, were upregulated in NLP compared with healthy skin (Fig 1, D) .
Biopsy specimens separated from the blood circulation were exposed to the T cell-activating antibody OKT-3 to further investigate alterations in the immune homeostasis in NLP, as previously described (Fig 1, E) . 20 Gene ontology identified that several pathways associated with cytokine and chemokine signaling were upregulated in epidermis from NLP after stimulation (Fig 1, F , and see Fig E1, B) , and expression of many induced genes was increased at baseline in active psoriasis plaques (Fig 1, G and H, and see Fig E1, C) . Overall, our data identified that local T-cell activation unraveled disease-associated responses in NLP.
IFN-a responses after T-cell activation in NLP can be induced by IFN-g exposure of human keratinocytes
Genes induced by type I interferons: myxovirus 1 (MX1), XAF1, PSMB8, and STAT1, were upregulated after T-cell stimulation in both NLP and skin with resolved psoriasis during continuous biologic treatment but not in healthy skin or skin of patients with resolved psoriasis after phototherapy (Fig 2, A) . Systemic IFN-a treatment induces exacerbation in patients with psoriasis, 27 and IFN-a-producing pDCs are proposed to initiate development of psoriasis plaques, 6 warranting further investigation of this pathway. MX-1, a GTPase with antiviral properties, is induced by both type I and III interferons 28, 29 and is highly expressed in patients with lesional psoriasis. 30 MX1 expression was 2-fold greater in epidermal CD45
2 cells from NLP compared with that from skin from healthy control subjects, although 10-fold less than that in skin from patients with lesional psoriasis (Fig 2, B) . In patients with resolved psoriasis, MX1 expression was between that seen in NLP and skin from patients with lesional psoriasis (see Fig E2, A, in this article's Online Repository at www.jacionline.org). Importantly, Keratin 16 gene expression was normalized in NLP, indicating that the keratinocyte differentiation was not affected in these samples at baseline (see Fig E2, A, in this article's Online Repository at www.jacionline.org).
Next, we explored potential sources of IFN-a in NLP. IFN-a was not detected in skin T cells (not shown), and similar numbers of pDCs were detected in NLP and healthy skin (Fig 2, C , and see Fig E2, B) . Thereafter, we tested whether T cell-derived cytokines associated with psoriasis directly affect type I interferon expression in the epidermis. In line with the sorted cells, increased mRNA expression of MX1 was evident in keratinocytes propagated from NLP, and both MX1 and IFN-a were induced in keratinocytes by J ALLERGY CLIN IMMUNOL VOLUME 143, NUMBER 4 IFN-g or IFN-a, which is in line with previous reports (Fig 2, D and  E) . 31 The density of epidermal T cells was similar in NLP and healthy skin (Fig 2, F, and see Fig E2, C and D) , but the density of IFN-g-producing CD4 cells was increased, with greater intracellular IFN-g expression in NLP (Fig 2, G and H , and see Fig E2, E) . These data highlight a combination of keratinocytes poised to type I interferon-related responses and accumulation of skin T cells poised to IFN-g production in NLP.
Accumulation of CCR6
1 CD4 1 and CD103 1 CD49a
2
CD8 T cells in NLP
Human skin is populated by several functionally distinct subsets of T cells. 16, 18 Although IL-17-producing CD103
1 CD49a 2 CD8 1 T cells accumulate in patients with lesional and resolved psoriasis, 17 detailed characterization of these markers in T cells from NLP is lacking. Epidermal T cells were situated in close contact with the basement membrane within slightly hyperplastic NLP (Fig 3, A and B) . A greater number of CD8 T cells was detected by using microscopy (Fig 3, B) compared with our assessment using flow cytometry (Fig 2) . Additionally, by using microscopy, a greater proportion of CD49a 2 CD8 1 T cells in NLP was found compared with that in healthy skin, but this difference did not reach statistical significance (Fig 3, D) . Flow cytometric analysis of cell suspensions provided further proof of increased frequency of CD103 
CD49a
2 T cells in epidermis from NLP, and T cells lacking CD69 were enriched in the dermis (Fig 3, E-G , and see Fig E3 in this article's Online Repository at www.jacionline.org). Additionally, epidermal CD4 T cells expressing CCR6, a chemokine receptor linked to IL-17 production, were enriched in NLP (Fig   3, H) . Our focused analysis of subsets of resident T cells indicated that several subsets associated with IL-17 production were enriched in NLP.
Epidermal CCR6-expressing T cells are effective with regard to IL-17 and IFN-g in NLP
Next, we directly explored expression of cytokines relevant to psoriasis pathology in the skewed pool of resident T cells in epidermis from NLP. A comprehensive overview of IL-17 expression in 13-parameter flow cytometric data was obtained by using a nonlinear dimensionality reduction algorithm with stochastic neighbor embedding (Fig 4, A) . Clusters of A, Visualization of epidermal CD8 cells (red), 49-6-diamidino-2-phenylindole dihydrochloride (DAPI; blue), and collagen IV (white) by using confocal microscopy. B and C, Assessment of CD8 T cells and epidermal thickness in healthy control subjects (HC; n 5 5) and NLP (n 5 6). D, Representative pictures of CD49a (green), CD8 (red), DAPI (blue), and collagen IV (white) and dot plots depicting counts of epidermal CD49a 2 CD8 1 T cells by using microscopy. HC, n 5 5; NLP, n 5 6. E-H, Flow cytometric data of epidermal (EPI) and dermal (DERMIS) cell suspension gated on live CD3 1 T-cell receptor (TCR) gd 2 cells. HCs, n 5 9; NLP, n 5 9; patients with plaque psoriasis (PP), n 5 7. IL-17A-producing and CCR6-expressing epidermal T cells were present in both healthy control skin and NLP. NLP had increased frequencies and densities of CCR6 1 T cells expressing IL-17, IFN-g, and IL-22 (Fig 4, B-D , and see Fig E4, A and B, in this article's Online Repository at www.jacionline.org). In contrast, phenotypes and functional profiles were similar between NLP and healthy skin in dermal T cells (Fig 4, B , and see Fig E4, C  and D) . Single-cell transcriptional profiling in murine inflammation has identified pathogenic CCR6
1 T cells coproducing IL-17 and IFN-g, and similar cells have been detected in patients with multiple sclerosis. 32 A distinct population of epidermal CCR6
1 T cells coproducing IL-17 and IFN-g was enriched in epidermis from NLP and patients with lesional psoriasis but not in healthy skin and in the dermis (Fig 4, E, and see Fig E4, C) . CD103 
CD49a
2 CD8 T cells produced IL-17 in epidermis from NLP, although CD103 
1 cells excelled in IFN-g production (see Fig E4, E and  F) . These data show that NLP harbors pathogenic resident T cells before the development of psoriasis pathology.
Fungal exposure induces the CCR6 ligand CCL20 in epidermis from NLP CCL20 and human b-defensin 2 (HBD2) are induced in IL-17-stimulated keratinocytes, 33 and both act as chemoattractants for CCR6-expressing cells. [34] [35] [36] In contrast, the chemokine CXCL10, which is also highly expressed in lesional psoriasis plaques (Fig 1, C and D) , 37 is induced by IFN-g. 38 ,39 Primary (Fig 4, B) and IL-22 1 (Fig 4, C) , IFN-g 1 (Fig 4, D) , and IL-17 1 IFN-g 1 (Fig 4, E) frequencies among CCR6 1 T cells. *P < .05.
keratinocytes propagated from NLP or healthy skin were exposed to cytokines (Fig 5, A) , and similar levels of CXCL10 and DEFB4/A (coding for HBD2) were induced by IFN-g and IL-17, respectively, in NLP and healthy skin (Fig 5, B , and see Fig E5, A, in this article's Online Repository at www.jacionline. org). In line with the upregulated expression of MX1 (Fig 2, B) , primary keratinocytes from NLP had greater baseline expression of CCL20 and responded to IL-17, IL-22, and IFN-g activation with accentuated induction of CCL20 (Fig 5, C and D) . In contrast, whole skin explants stimulated with IL-17 did not display differential expression in CCL20 between NLP and healthy skin (see Fig E5) . Both CCL20 and HBD2 have antifungal properties, [40] [41] [42] and we next exposed whole skin biopsy specimens to fungal products. In line with our findings in primary keratinocytes, heat-killed C albicans increased CCL20 and DEFB4A/B expression in FIG 5 . Accentuated epidermal CCL20 expression responses after exposure to fungal products in NLP. A, Schematic of experimental setup. B-D, Confluent primary keratinocytes were exposed to 16 hours of stimulation with cytokines. Fig 5, B and C, DEFB4A/B and CCL20 expression in cytokine-stimulated keratinocytes obtained from skin from healthy control subjects (HC) and NLP. Pooled data from 2 experiments. Fig 5, D , Secreted CCL-20 measured in keratinocyte supernatants with Luminex technology. RQ, Relative quantification. E, CCL20 and DEFB4A/B expression in skin explants after 16 hours of stimulation with mannan from Saccharomyces cerevisiae (SC) and heat-killed Candida albicans (CA; n 5 5 for CA and n 5 9 to 11 for other groups). *P < .05. NS, Not significant. J ALLERGY CLIN IMMUNOL VOLUME 143, NUMBER 4 epidermis from NLP but not healthy epidermis (Fig 5, E) . Similar responses for CCL20 were noted against mannan from the cell wall of S cerevisiae (Fig 5, E) but not Malassezia furfur (data not shown). Our data indicate that exacerbated skin responses to microbial products influence recruitment of CCR6-expressing T cells to the skin in NLP.
DISCUSSION
Psoriasis is a chronic disease in which the majority of patients display remitting/relapsing pathology confined to a few areas of the skin. Local alterations in skin homeostasis are obvious in active and resolved lesions, with accumulation of disease driving resident T cells. The de novo evolution of plaques in nonaffected skin in patients with established disease is less studied, but local production of IFN-a by pDCs 6 and translocation of resident T cells from the dermis to epidermis 6 have been proposed to be essential for initiation of individual lesions. Here we identified that CCR6
1 resident T cells prone to produce IL-17 or IL-22 are enriched in NLP and that these cells have the potential to trigger keratinocyte-derived type I interferon responses through IFN-g. Furthermore, we show that microbial challenge and inflammatory responses lead to enhanced CCL20 responses in NLP, which can attract and maintain CCR6-expressing cells (Fig 6) .
The initial steps in the evolution of new psoriatic lesions occur subclinically out of the dermatologist's sight, which complicates sampling of this process. In patients with severe psoriasis, nonlesional skin exhibits an altered transcriptional profile with upregulation of expression of genes associated with the disease compared with that seen healthy skin. 7 In contrast, we analyzed 112 transcripts associated with skin inflammation and psoriasis in skin from a small cohort of patients with mild psoriasis, and our baseline gene expression in NLP clustered together with that in patients with resolved psoriasis and healthy skin and was clearly distinct from psoriatic lesions. After in situ activation of local T cells in NLP, we found that IFN-a signaling was induced in epidermal cells. We detected increased densities and frequencies of T cells poised to produce IFN-g in NLP and show that IFN-a was induced by IFN-g in keratinocytes, which is in line with previous studies, 43 introducing an alternative source of type I interferons during induction/initiation of psoriasis. 3, 44 In contrast, local application of imiquimod induces production of type I interferons from pDCs, and intense local inflammation but does not trigger bona fide psoriasis plaques or exacerbated inflammatory responses in patients with psoriasis compared with healthy control subjects, indicating that additional local factors are necessary to initiate the disease. 45 Accumulation of either CD4 15 or CD8 7 T cells in uninvolved skin of patients with psoriasis has been reported, and we found increased numbers of CD8 T cells in microscopic specimens but not in cell suspensions assessed by using flow cytometry, highlighting the risk of underestimating cell numbers in enzymatically prepared samples. Nevertheless, our multiparameter analysis highlighted that epidermis from NLP contains skewed populations of resident T cells, with accumulation of resident CD8 T cells lacking CD49a expression and CCR6 1 T cells poised to produce IL-17, IL-22, and IFN-g. Direct comparison between skin from patients with resolved psoriasis and NLP was not possible because of different experimental setups during the assessment of cytokine production, but our study points toward greater frequencies of IFN-g-producing and lower frequencies of IL-17-and IL-22-producing resident T cells in NLP compared with previously published work from patients with resolved and active psoriasis. 18, 19 In line with recent findings from patients with UVB-treated psoriasis, 20 it is possible that the dominance of IFN-g-over IL-17-producing T cells in NLP prevents induction of psoriasiform tissue responses during steady state. Alternatively, the density of pathogenic resident T cells is too low in epidermis from NLP to trigger tissue remodeling and plaque development.
Compartmentalization of resident T cells is striking in healthy and diseased human skin, with a greater frequency of cytokine-producing cells in the numerically much smaller population of intraepithelial cells compared with dermal cells. 16, 46 Accordingly, the nonlesional epidermis contained a small population of resident T cells capable of responding to stimulation with psoriasis-driving cytokines and a larger population of indolent dermal T cells. In parallel with recent data from imiquimod application on nonlesional skin of patients with psoriasis, 45 it is obvious that the presence of resident T cells poised to produce psoriasis-driving cytokines is not enough to initiate plaque formation or the K€ obner phenomena, and de novo lesions develop in this cohort of patients after sampling. A number of years ago, Nestle et al 6 showed that resident T cells in patients with nonlesional psoriasis were capable of inducting psoriasiform inflammation in human skin transplanted to immunocompromised mice. Pathology was dependent on infiltration of CD8 1 T cells into the epidermal compartment, indicating that a certain density of cytokine-producing cells is necessary to activate keratinocytes and initiate an amplification loop, resulting in psoriasiform inflammation. Intriguingly, skin from patients with psoriasis regardless of disease state contains a subset of CD49a 1 T cells that are highly effective coproducers of IFN-g and IL-17 in contrast to healthy subjects and patients with vitiligo. 16 The IL-17 pathway is activated in both antifungal responses and in patients with psoriasis, and several proposed biomarkers of psoriasis severity, such as CCL20 and defensins, have potent antifungal properties. [40] [41] [42] Human skin is colonized by fungi, including Candida and Saccharomyces species.
47-49 NLP responded with potent CCL20 induction to exposure to both C albicans and mannan, a fungal cell-wall component from S cerevisiae. Our data highlight that keratinocytes from skin from healthy control subjects and patients with psoriasis respond differently not only to cytokine exposure, as described previously, 11, 50, 51 but also to components of common fungi present in the environment.
In our experimental setup a dividing monolayer of keratinocytes propagated from patients with psoriasis, but not full-thickness skin biopsy specimens, showed exacerbated production of CCL20 after IL-17 stimulation compared with keratinocytes from healthy donors. The strict suprabasal localization of CCL20 protein and mRNA in patients with active psoriasis 34, 52 indicates that the CCL20 signal induced might have been diluted out by unresponsive differentiated keratinocytes in the stratified skin biopsy specimen. Among the gene variations that predispose patients to psoriasis, the PSORS2 locus has been linked to CARD14 mutations, with a consequent increase in CCL20 expression in keratinocytes. 53 In conclusion, increased densities of epidermal IL-17-and IL-22-producing skin-resident CCR6 1 T cells might be a consequence of an aggravated and genetically determined epidermal CCL20 response to microbes in NLP. Additionally, we propose a mechanism by which IFN-g 1 T cells induce type I interferon signaling in keratinocytes. Overall, our data point to profound differences between NLP and skin from healthy control subjects. Our combined analysis placed NLP on a spectrum of altered tissue homeostasis together with resolved or lesional psoriasis.
